DK1374952T3 - Anvendelse af flumazenil ved udvikling af et lægemiddel til behandling af alkoholafhængighed - Google Patents

Anvendelse af flumazenil ved udvikling af et lægemiddel til behandling af alkoholafhængighed

Info

Publication number
DK1374952T3
DK1374952T3 DK02716090T DK02716090T DK1374952T3 DK 1374952 T3 DK1374952 T3 DK 1374952T3 DK 02716090 T DK02716090 T DK 02716090T DK 02716090 T DK02716090 T DK 02716090T DK 1374952 T3 DK1374952 T3 DK 1374952T3
Authority
DK
Denmark
Prior art keywords
flumazenil
drug
alcohol dependence
development
treatment
Prior art date
Application number
DK02716090T
Other languages
Danish (da)
English (en)
Inventor
Ibanez Juan Jose Legarda
Original Assignee
Hythiam Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hythiam Inc filed Critical Hythiam Inc
Application granted granted Critical
Publication of DK1374952T3 publication Critical patent/DK1374952T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
DK02716090T 2001-01-17 2002-01-10 Anvendelse af flumazenil ved udvikling af et lægemiddel til behandling af alkoholafhængighed DK1374952T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200100106 2001-01-17

Publications (1)

Publication Number Publication Date
DK1374952T3 true DK1374952T3 (da) 2007-01-02

Family

ID=8496426

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02716090T DK1374952T3 (da) 2001-01-17 2002-01-10 Anvendelse af flumazenil ved udvikling af et lægemiddel til behandling af alkoholafhængighed

Country Status (23)

Country Link
US (2) US7348321B2 (pt)
EP (1) EP1374952B1 (pt)
JP (2) JP2004519461A (pt)
KR (1) KR100712570B1 (pt)
CN (1) CN1486205A (pt)
AT (1) ATE338575T1 (pt)
AU (1) AU2002226427B2 (pt)
BR (1) BR0206549A (pt)
CA (1) CA2433833C (pt)
CR (1) CR7049A (pt)
CY (1) CY1107500T1 (pt)
DE (1) DE60214527T2 (pt)
DK (1) DK1374952T3 (pt)
ES (1) ES2269661T3 (pt)
HK (1) HK1061661A1 (pt)
IL (1) IL156798A0 (pt)
MX (1) MXPA03006411A (pt)
NZ (2) NZ527583A (pt)
PT (1) PT1374952E (pt)
RU (1) RU2300378C2 (pt)
UA (1) UA78199C2 (pt)
WO (1) WO2002056964A1 (pt)
ZA (1) ZA200305922B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192271A1 (en) 2003-07-15 2005-09-01 Hythiam, Inc. Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
US20060172998A1 (en) * 2005-02-03 2006-08-03 Halikas James A Method of preventing relapse in the abstinent substance dependent individual
US20060172996A1 (en) * 2005-02-03 2006-08-03 Halikas James A Method of preventing relapse in the abstinent substance dependent individual
EP1868593A2 (en) * 2005-04-07 2007-12-26 Hythiam, Inc. Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence
US20060263304A1 (en) * 2005-05-23 2006-11-23 Halikas James A Method of controlling alcohol intake and reversing alcohol effects
SG183696A1 (en) * 2007-08-06 2012-09-27 Biotie Therapies Inc Medicaments comprising nepicastat for use in treating dependence on a substance
EP2186517A4 (en) * 2007-08-08 2010-08-18 Ibanez Juan Jose Legarda USE AND METHODS OF USING A SEROTONIN3 (5-HT3) RECEPTOR ANTAGONIST AND CHLORIDE CHANNEL MODULATOR FOR THE TREATMENT OF DRUG OR DRUG ADDICTION OR DEPENDENCE OR CENTER NERVOUS DISORDERS
AU2010215075B2 (en) * 2009-02-20 2015-08-20 Palmaya Pty Ltd Pharmaceutical preparation and delivery system
US8930050B2 (en) * 2009-04-29 2015-01-06 Marine Canada Acquisition Inc. Method and system for increasing or decreasing engine throttle in a marine vessel
US20100280684A1 (en) * 2009-04-29 2010-11-04 Pierre Garon Synchronization of shift and throttle controls in a marine vessel
US8347859B2 (en) * 2009-04-29 2013-01-08 Marine Canada Acquisition Inc. Automatic throttle calibration in a marine vessel
US8387589B2 (en) * 2009-04-29 2013-03-05 Marine Canada Acqusition Inc. Position sensor for an output shaft used in a shift and throttle system
US8406944B2 (en) * 2010-02-10 2013-03-26 Pierre Garon Control system and method for starting and stopping marine engines
US8845490B2 (en) 2010-02-10 2014-09-30 Marine Canada Acquisition Inc. Method and system for delaying shift and throttle commands based on engine speed in a marine vessel
US8182396B2 (en) * 2010-02-10 2012-05-22 Marine Canada Acquisition In.c Method and system for delaying shift and throttle commands based on engine speed in a marine vessel
AU2012221704B2 (en) 2011-02-23 2013-12-05 Coeruleus Ltd. Flumazenil complexes, compositions comprising same and uses thereof
RU2468799C1 (ru) * 2011-08-03 2012-12-10 Общество с ограниченной ответственностью "Урал Крафт" Способ купирования алкогольного абстинентного синдрома посредством блокады бензодиазепиновых рецепторов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519017A (en) * 1990-03-29 1996-05-21 Lts Lohmann Therapie-Systeme Gmbh + Co. Kg Pharmaceutic formulation for the treatment of alcoholism
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
GB9420010D0 (en) 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
US20030176456A1 (en) * 2001-12-21 2003-09-18 June Harry L. Methods for reducing alcohol cravings in chronic alcoholics
US6740677B2 (en) 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids

Also Published As

Publication number Publication date
HK1061661A1 (en) 2004-09-30
NZ539400A (en) 2006-04-28
DE60214527D1 (de) 2006-10-19
RU2300378C2 (ru) 2007-06-10
AU2002226427B2 (en) 2006-11-16
PT1374952E (pt) 2006-12-29
NZ527583A (en) 2006-03-31
MXPA03006411A (es) 2004-12-02
CR7049A (es) 2008-02-20
BR0206549A (pt) 2004-02-25
IL156798A0 (en) 2004-02-08
ATE338575T1 (de) 2006-09-15
KR100712570B1 (ko) 2007-05-02
CY1107500T1 (el) 2013-03-13
EP1374952A1 (en) 2004-01-02
US20040092509A1 (en) 2004-05-13
ES2269661T3 (es) 2007-04-01
JP2004519461A (ja) 2004-07-02
EP1374952B1 (en) 2006-09-06
ZA200305922B (en) 2004-08-02
JP2008201796A (ja) 2008-09-04
CN1486205A (zh) 2004-03-31
KR20040020046A (ko) 2004-03-06
UA78199C2 (en) 2007-03-15
RU2003125274A (ru) 2005-01-20
US20080132492A1 (en) 2008-06-05
DE60214527T2 (de) 2007-04-05
US7348321B2 (en) 2008-03-25
CA2433833A1 (en) 2002-07-25
CA2433833C (en) 2009-06-02
WO2002056964A1 (es) 2002-07-25

Similar Documents

Publication Publication Date Title
CY1107500T1 (el) Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ
ATE359077T1 (de) Orale gabe von 6-hydroxy-oxymorphon als analgetikum
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
CY1106845T1 (el) Χρηση της φλουμαζενιλης για την παρασκευη ενος φαρμακου για την αγωγη της εξαρτησεως απο την κοκαϊνη
BR0015974A (pt) Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
DE60126923D1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
NO20025394D0 (no) Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer
DK1656131T3 (da) Anvendelse af betain til behandling claudicatio intermittens
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
SE0004827D0 (sv) Therapeutic compounds
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
BR0115881A (pt) Emprego de compostos ciclohexanona substituìdos de 6-dimetilaminometil-1-fenil para a terapia da incontinência urinária
DE60114597D1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente
BR0211323A (pt) Combinação de ingredientes ativos, uso de uma combinação de ingredientes ativos e método de terapia farmacológica de dependência de nicotina
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen